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Abstract
Background: Detection of genomic DNA copy number variations (CNVs) can provide a complete and more
comprehensive view of human disease. It is interesting to identify and represent relevant CNVs from a genome-
wide data due to high data volume and the complexity of interactions.
Results: In this paper, we incorporate the DNA copy number variation data derived from SNP arrays into a
computational shrunken model and formalize the detection of copy number variations as a case-control
classification problem. More than 80% accuracy can be obtained using our classification model and by shrinkage,
the number of relevant CNVs to disease can be determined. In order to understand relevant CNVs, we study their
corresponding SNPs in the genome and a statistical software PLINK is employed to compute the pair-wise SNP-
SNP interactions, and identify SNP networks based on their P-values. Our selected SNP networks are statistically
significant compared with random SNP networks and play a role in the biological process. For the unique genes
that those SNPs are located in, a gene-gene similarity value is computed using GOSemSim and gene pairs that
have similarity values being greater than a threshold are selected to construct gene networks. A gene enrichment
analysis show that our gene networks are functionally important.
Experimental results demonstrate that our selected SNP and gene networks based on the selected CNVs contain
some functional relationships directly or indirectly to disease study.
Conclusions: Two datasets are given to demonstrate the effectiveness of the introduced method. Some statistical
and biological analysis show that this shrunken classification model is effective in identifying CNVs from genome-
wide data and our proposed framework has a potential to become a useful analysis tool for SNP data sets.
Background
Copy number variation (CNV) is defined as a genomic
segment range from one kilobase to several megabases
in size, in which copy number differences have been
observed by comparison of two or more reference gen-
omes [1,2]. Human beings ordinarily have two copies of
each autosomal region, one per chromosome. CNVs can
be caused by genomic rearrangements such as inver-
sions, deletions and duplications.
The fact that DNA copy number variation is a wide-
spread and common phenomenon among human beings
was first discovered [3,4] following the completion of
the human genome project. The high variability of the
copy number throughout the human genome have been
found by investigating on 270 HapMap individuals [5,6].
Various studies have been developed for genome-wide
CNV analysis to suggest their significant role in under-
standing human genetics. Redon et al. [7] published the
first comprehensive and global map of CNVs in a gen-
ome-wide scale for making the beginning of large-scale
copy number analysis. Comparative genomic hybridiza-
tion (CGH) [8] and array-based comparative genomic
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any medium, provided the original work is properly cited.hybridization [9] can detect gains and losses of genomic
segments. Based on CGH, Wang et al. [10] proposed a
new algorithm “Cluster Along Chromosomes” (CLAC),
which builds hierarchical clustering-style trees along
each chromosome and selects the interesting clusters by
controlling False Discovery Rate (FDR) at a certain level.
Bayesian model is a popular method for CNV detection.
Pique-Regi et al. [11] exploited the use of piecewise con-
stant (PWC) vectors to represent genome copy number
and sparse Bayesian learning (SBL) to detect CNA
breakpoints. Wu et al. [12] implemented Bayesian seg-
mentation approach to carry out segmentation and
assigning copy number status simultaneously. Recently,
Chen et al. [13] used the mean and variance change
point model (MVCM) to detect CNVs or breakpoints
with an approximate p-value for statistical testing. In
addition, Oldridge et al. [14] quantitatively evaluated
several processing and segmentation strategies when
short-sequence oligonucleotide arrays are applied and
provide guidelines to optimize performance based on
study-specific objectives.
Besides the above mentioned CNV detection methods,
high-density single nucleotide polymorphism (SNP)
arrays are becoming more and more popular in CNV
detection. The main reason is that the inheritance pat-
tern and linkage disequilibrium of CNVs are similar to
those of the SNPs [6,7]. Zhao et al. [15] measured the
locus-specific hybridization intensity by hybridizing
genomic representations of both DNA to SNP arrays to
detect some novel CNVs in cancer samples. Huang et
al. [16] proposed an algorithm that used whole genome
sampling analysis (WGSA) by jointly measuring perfect
match intensity and discrimination ratios to identify
copy number changes. An QuantiSNP algorithm [17]
described in 2007 used Objective Bayes Hidden-Markov
Model (OB-HMM) by incorporating log R ratio and B
allele frequency to set certain hyperparameters as priors,
and using a novel re-sampling framework to calibrate
the model to a fixed false positive error rate for CNVs
detection. Wang et al. [18] designed a tool named
PennCNV, a hidden Markov model (HMM) based
approach, for kilobase-resolution detection of CNVs by
combining multiple sources of information together, not
only the total signal intensity and allelic intensity ratio
of each SNP marker, but also the neighboring distances,
the allele frequency and the pedigree information.
Recently, disease classification using copy number var-
iation data has been demonstrated by several groups
[19-22]. The motivation of this kind of method is that
appropriate machine learning models for disease classifi-
cation using copy number variation data will be effective
not only for clinical treatment, but also for identification
of disease susceptibility loci. Generally, copy numbers at
probe loci are used directly as features. In a CNV data
set, the association between a disease and a set of rele-
vant CNVs are investigated. Patients and normals are
often categorized in groups according to their copy
number changes. Thousands of CNVs in different
regions of chromosomes are used to describe character-
istics of patient/normal samples.
When many CNVs are used to detect the association
between a disease and multiple marker genotypes, we
expect in a typical data set that contains the CNV data
of several thousands of CNVs in different individuals, it
is common to find only several numbers of copy num-
ber positions having genetic patterns that are highly spe-
cific to each group of individuals. The CNVs are called
the relevant CNVs, as opposed to the irrelevant CNVs
that do not help much in identifying the group (i.e.,
individuals of the same type). Due to the large number
of CNVs being irrelevant to each group, two individuals
in the same group could have low similarity when mea-
sured by a simple similarity function that consider the
characteristics of all CNVs. The groups may thus be
undetectable by classification algorithms. Here, we are
interested in the development of high-dimensional
numerical classification algorithm that can identify
group of individuals and their relevant CNVs, i.e., detect
the association between a disease and multiple marker
variations. In this paper, we address this problem by
applying a shrunken dissimilarity measure to copy num-
ber variation values derived from genome-wide SNP
genotyping data. Performance was measured via cross-
validation classification accuracy. By shrinkage, the
number of relevant CNVs can be determined. In order
to understand relevant CNVs, we study their corre-
s p o n d i n gS N P si nt h eg e n o m ea n das t a t i s t i c a ls o f t w a r e
PLINK is employed to compute the pair-wise SNP-SNP
interactions, and identify SNP network based on their
P-values. Some statistical analysis are done to illustrate
the significance of our selected SNP networks. For the
unique genes that those SNPs are located in, a gene-
gene similarity value is computed using GOSemSim and
gene pairs that has a similarity value being greater than
a threshold are selected to construct gene networks. A
gene enrichment analysis are done to show that some
molecular functions and biological process are signifi-
cantly associated with our gene networks. The whole
framework indicates that our classification model is effi-
cient in high dimensional CNV detection and SNP and
gene networks constructed afterwards have relationships
directly or indirectly to disease study.
The outline of this paper is given as follows. In Sec-
tion 2, we propose the LRR calculation for signal inten-
sities, the shrunken dissimilarity measure to analyze
CNV data classification and the logistic model to calcu-
late SNP interactions. In Section 3, we present experi-
mental results on two real CNV data sets derived from
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sponding SNP and gene networks for statistical and bio-
logical analysis. Finally, we give concluding remarks in
Section 4.
Methods
LRR calculation
There are many available tools that can be used to do
genotyping call and Log R Ratio (LRR) calculation, such
as Birdsuite [23], CNAG [24], dChip [25,26] and GLAD
[27]. We calculated LRR values using PennCNV [18],
which is a public available software for copy number
variation detection from SNP genotyping arrays. For
each SNP in a genome-wide data, the raw signal inten-
sity values for its two alleles A and B are measured and
then subject to a normalization procedure. The normal-
ized signal intensity values should reveal three clusters
(AA, AB, BB) representing three distinct genotypes. A
genotype calling is a genotype assignment based on
these three canonical clusters.
The normalization procedure produces X and Y
values for each SNP, representing the experiment-wide
normalized signal intensity on alleles A and B, respec-
tively. One additional measurement will then be calcu-
lated for each SNP, where R = X + Y refers to the total
signal intensity. As for a normalized measure of total
signal intensity, the LRR value for each SNP is then
calculated as
LRR = log2(Robserved/Rexpected) (1)
where Rexpected is computed from linear interpolation
of canonical genotype clusters [28]. LRR refers to the
logarithm (in base 2) of the total observed normalized
intensity Robserved of the two alleles A and B relative to
the expected Rexpected. For normal diploid genotypes,
LRR should fluctuate randomly around zero.
Shrunken centroid method
It is well-known that DNA microarray data, which can
simultaneously measure the expression level of thou-
sands of different genes, have been successfully used to
identify genetic heterogeneity of disease. However, mir-
coarray data typically has a large number of genes (fea-
tures) and relatively few samples (observations),
meaning that conventional machine learning methods
may fail when applied to such data. The Prediction Ana-
lysis for Microarrays (PAM), has recently been reported
as a potential powerful tool for microarrays analysis,
which is based on the technique of nearest shrunken
centroid [29,30]. Nearest shrunken centroid is the “de-
noised” version of simple nearest centroid classification.
The main idea of nearest centroid classification is to
compare test sample to each class centroid. The class
whose centroid the test sample is closest to is the pre-
dicted class for test sample. The centroid is the average
value for each feature (or attribute) in each class, nor-
malized by the pooled within-class standard deviation.
The nearest shrinkage centroid classification shrinks
each centroid toward the overall centroid for all classes
by a certain amount, which is called a “threshold”. After
the overall centroid is set to zero, this shrinkage is to
move the centroid to zero by the threshold, i.e., if the
value of centroid in magnitude is larger than the thresh-
old, it is subtracted by the threshold; if it is less than
the threshold, it is set to zero, so the corresponding fea-
ture disappears, and it isn’t used for the following classi-
fication. By doing so, nearest shrunken centroid can find
out the minimal subset of genes which succinctly char-
acterize each class. Shrunken centroid method is tradi-
tionally used to deal with microarray data. In this paper,
we adopt this method for copy number variation values
derived from SNP genotyping arrays. The normalized
signal intensity Log R Ratio (LRR) value in each probe
loci calculated from existing software, which we will
give a detailed description in the next subsection, will
be considered as a unique feature.
Suppose there are n samples, p CNVs, and K classes.
For ith CNV, the class centroid xij is the average value
of LRR values within one class, and the overall centroid
xi i st h ea v e r a g ev a l u eo v e ra l lc l a s s e s .T h ed i f f e r e n c e
between class centroid and overall centroid is normal-
ized by pooled with-class standard deviation as follows:
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Ck denote the indices of the nk samples in class k, and
s0 is a positive constant included to prevent the possibi-
lity that a CNV with a low LRR level could produce a
large dij. Equation (2) can be rewritten as:
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Then the shrunken centroid is defined as:
xx m s s d ik i k i ik
’’ () =+ + 0 (4)
where dd d ik ik ik
’ ( )(| | ) =− Δ + sign ,a n dt+ = t if t >0
and zero otherwise. The parameter Δ is usually sought
by cross-validation with minimal classification error
rate. Note that if dik
’ = 0 for all k for a given i,t h e na l l
of the shrunken centroids are zero, and the ith CNV
does not contribute to the classification process. For
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by the nearest shrunken centroid:
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πk is the prior probability of class k.
Logistic model to calculate SNP interactions
As our experimental data sets are both disease-trait sam-
ples, it is feasible to test epistasis using PLINK to [31]
detect SNP-SNP interactions, which is a free, open-source
whole genome association analysis toolset, designed to
perform a range of basic, large-scale analysis in a compu-
tationally efficient manner. All pairwise combinations of
input SNPs can be tested using a logistic regression
model, which is based on allele dosage for each SNP, A
and B, and fits the model in the form of (5)
Y~b0 + b1.A + b2.B + b3.AB + e (5)
The test for interaction is based on the coefficient of
b3, therefore only considers allelic by allelic epistasis. We
focus on symmetrical cases in our study, that means only
unique pairs are analysed, for example, if SNP1*SNP2 is
performed, SNP2*SNP1 will not be calculated again. The
c
2 statistics is applied and the odds ratio for interaction
is interpreted in the standard manner: a value of 1.0 indi-
cates no effect.
Results and Discussion
WTCCC Type 1 Diabetes study
Data set and preprocessing
T h ec o r es t u d yo ft h eW e l l c o m eT r u s tC a s eC o n t r o l
Consortium (WTCCC) comprised an analysis of genetic
signals from each of seven common human diseases
(type 1 diabetes, type 2 diabetes, coronary artery disease,
hypertension, bipolar disorder, rheumatoid arthritis and
Croh disease) [32]. Genotyping for type 1 diabetes
(T1D) study was conducted by Affymetrix using the
(“commercial”) Affymetrix 500K chip in 3504 samples
with 2000 cases and 1504 controls.
The quantile normalized signal intensity data, which
were generated from the Affymetrix intensity (‘CEL’)
files and used as input to the Chiamo genotype calling
program, was downloaded from WTCCC webpage and
appropriately prepared according to the requirements of
input file formats of PennCNV. A biological literature
searching indicates that in chromosome 6, there are
some well-known T1D related genes. Therefore, we
chose chromosome 6 as an example to demonstrate our
method. There are 31470 unique SNP loci in this chro-
mosome, 1 markers have complete genotyping failure
with confidence threshold of 0.01, 1042 markers do not
have at least two types of genotypes, 2460 markers have
abnormal patterns, so there are 27967 SNP markers
have been analyzed to construct canonical clustering
positions.
Classification results
After a 10-fold cross validation setting, 3154 samples
were selected as training data and the remaining 350
samples would be the testing data. The highest classifi-
cation accuracy (correctly classified samples in testing
data sets in the 10-fold cross validation) in the 10 trials
is 80%. The parameter Δ was tuned to obtain the high-
est accuracy in the test. Figure 1 shows the relationships
between Δ values and accuracies obtained in this trial.
We can observe that when the value of Δ is increased
from 0 to 20, the classification accuracy fluctuates and
achieves the highest one of 80.00% when Δ =1 0 .56.
Our method can select 63 SNPs, 25 of them are
located in gene coding areas. In order to investigate
how this small set of SNPs can distinguish case and
control people so well, we further discovered the distri-
bution of each SNP in case and control group. Table 1
shows the average and variance of LRR values in each
SNP position within case and control group respectively.
We only considered the SNPs that are located in gene
coding areas here. We gave a ranking for these SNPs
based on the parameter of dik
’ mentioned in the pre-
vious section, which can be considered as the contribu-
tion of this SNP to the classification problem. We can
see that in each SNP position, the distribution of LRR
values within case people and control people are signifi-
cantly different, which are consistent with our classifica-
tion results.
SNP network construction and analysis
All the SNPs selected by our method can be divided
into two categories, those are located in gene coding
areas and those are not. We did a statistical analysis
between these two categories of SNPs using PLINK [31].
All pairwise combinations of SNPs can be tested. Odds
ratio for interaction, c
2 statistic and asymptotic P-value
will be provided in the output file. When adopted differ-
ent thresholds, different kinds of SNP networks can be
constructed. Here “threshold” means only SNP pairs
that have a P-value smaller than this threshold will be
considered and be included in the SNP network. By
constructing these SNP networks, we can figure out
some potential SNP-SNP interactions that are still
unknown. Table 2 shows a detailed characteristics of
SNP networks under different thresholds, including the
number of SNP networks, the number of nodes and
edges in each individual network. As we were interested
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n e t w o r k sw h e r et h en u m b e ro fS N P sa r em o r et h a n
one. We can see that the number of networks increases
when the significant P-value decreases as one single net-
work can be separated into several smaller ones. How-
ever, when P-value further decreases, the number of
networks is reduced until there is only one left as there
are too small SNPs to form a network.
To further utilize and benefit from these SNP
networks selected by our method, we next performed
some statistical analysis. For each network under one
particular threshold, we randomly picked the same
number of SNPs with our selected SNP network to get
a random SNP network, calculated all the pairwise SNP-
SNP interactions and got the average value of all the P-
values within this random network. Such process were
repeated 500 times. Table 3 shows the significance of
our selected networks compared with random ones. As
SNP networks under threshold of 0.1 almost involve all
the SNPs selected by our shrunken classification model,
we chose this threshold as an example to further ana-
lyze. Figure 2 shows the two SNP networks under this
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Figure 1 Relationship between Δ and accuracy in chromosome 6 of T1D study. Illustration of the accuracy obtained in chromosome 6 of
Type 1 diabetes data set when change Δ value from 0 to 20. For chromosome 6, in each trial, all the 3504 samples of both control and case were
randomly divided into 10 equal partitions. For each of the 10 partition groups, we selected one of them as testing set and the remaining nine of
them were considered as training sets. 10 trials were considered and the results were collected based on this 10-fold cross validation procedure.
This figure was drawn based on one of these ten trails when the highest accuracy (accuracy refers to the percentage of correctly classified samples
over all test samples) was obtained. X axis refers to Δ value, it increases from 0 to 20. Y axis refers to the accuracy obtained in chromosome 6 when
using our method, it fluctuates when different Δ values are applied and the highest accuracy is obtained when Δ is equal to 10.56.
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but the other one is much bigger, including 49 unique
SNPs. Figure 3 is the cumulative distribution of the
average P-values for all 500 samples (each with 49
SNPs). Compared with the distribution of random sam-
ples, which was with mean of 0.5645 and variance of
0.1008, our selected SNP network (average P-value is
0.0450) is very significant, with significance value of
1.2765 × 10
–7.
Gene network construction and analysis
Our method can select 63 SNPs, 25 of them are located
in gene coding areas, and these 25 SNPs belong to 24
unique genes, which are all shown in Table 4. After
checking with NCBI, we found that some of the genes
that our selected SNPs located in are directly or indir-
ectly related to diabetes. For example, GMDS refers to
GDP-mannose 4,6-dehydratase, which catalyzes the con-
version of GDP-mannose to GDP-4-keto-6-deoxyman-
nose, and it has been verified that mannose-binding
lectin is a predictor of Type 1 Diabetes [33]. MTHFD1L
is an enzyme involved in THF synthesis in mitochon-
dria, and mutations of mitochondria strongly associate
with diabetes [34]. And also for LAMA2, whose full
name is laminin, alpha 2, is a major component of the
basement membrane, the abnormal level of it has been
reported to have significant relationship to the presence
of diabetes [35].
We computed all the pair-wise functional similarities of
these 24 gene products using GOSemSim, which is an
open source and open development software project for
the analysis and comprehension of genomic data running
in the platform of R Bioconductor package [36]. GOSem-
Sim estimates the similarity scores of gene pairs accord-
ing to their Gene Ontology (GO) [37] terms: molecular
function (MF), biological process (BP) and cellular com-
ponent (CC). In this paper, we only considered two of
these terms: MF and BP and adopted Rel’s method [38]
to compute the similarity values, which is based on the
information content of the GO terms and define informa-
tion content as the frequency of each term occurs in the
GO corpus. Afterwards, gene pairs that have a similarity
value being greater than a threshold, were selected to
construct a gene network using Cytoscape [39]. As we
were interested at gene-gene interactions, and we only
considered the networks where the number of genes are
more than one. In Table 5, we showed the number of
gene networks formed by using different threshold values
and the number of pairs of genes involved.
We can see in Table 5 that the number of gene net-
works increases when the threshold value increases as
more networks are formed. However, when threshold
value further increases, the number of networks is
reduced until there is only one network left. According
to Table 5, we selected the threshold of 0.15 for analysis
as the number of gene networks is highest than those
using other threshold values. Figure 4 demonstrates the
gene networks constructed by our method when thresh-
old is equal to 0.15. Gene pairs that are grouped in the
same network suggested a strong potential for interac-
tion effects in biological process. We can see from this
figure that there are 3 networks, including 12 pairs and
11 unique genes.
We found some interesting relationships from SNP
and gene networks. For example, for SNPs rs9321142
and rs9371491, which are interacted in the same SNP
network under P-value of 0.1 in Figure 2, their
Table 1 Distribution of LRR values for selected SNPs of
T1D study.
SNP ID dik
’
Control Case
mean variance mean variance
rs6940177 2.3940 0.0522 0.0431 -0.1845 0.0402
rs17209874 2.2398 0.1071 0.0288 -0.0926 0.0218
rs9479373 2.1075 0.1027 0.0187 -0.0838 0.0213
rs3778077 1.8133 0.0937 0.0157 -0.1180 0.0450
rs16875181 1.6937 0.1107 0.0216 -0.1033 0.0454
rs7754428 1.6853 0.0968 0.0199 -0.0921 0.0262
rs6902158 1.6838 0.0888 0.0278 -0.1067 0.0244
rs6912853 1.3226 0.1116 0.0254 -0.0770 0.0274
rs991974 1.2833 0.0912 0.0177 -0.1010 0.0351
rs643394 1.2636 0.1146 0.0244 -0.0943 0.0471
rs9397339 1.1925 0.0906 0.0177 -0.0906 0.0264
rs319123 1.1473 0.1015 0.0199 -0.0863 0.0309
rs352095 0.9764 0.1097 0.0380 -0.0873 0.0310
rs1738262 0.7388 0.0979 0.0249 -0.0860 0.0311
rs7760230 0.5918 0.0914 0.0171 -0.0730 0.0204
rs10947885 0.4503 0.0663 0.0166 -0.1074 0.0308
rs1334689 0.4209 0.1052 0.0197 -0.0775 0.0361
rs1406882 0.3947 0.1047 0.0236 -0.0837 0.0402
rs1563666 0.2513 0.0916 0.0329 -0.0846 0.0245
rs9321142 0.2245 0.0843 0.0140 -0.0719 0.0210
rs2073012 0.1519 0.0989 0.0281 -0.0668 0.0208
rs11154452 0.1286 0.0847 0.0243 -0.0905 0.0324
rs9394755 0.1208 0.0980 0.0270 -0.0714 0.0257
rs9371491 0.0910 0.0832 0.0151 -0.0732 0.0217
rs6918886 0.0069 0.0951 0.0220 -0.0922 0.0473
Table 2 Characteristics of SNP networks in different
thresholds of T1D study.
PLINK
thresholds
NO. of
networks
NO. of SNPs NO. of SNP pairs
0.1 2 1(2), 2(49) 1(1), 2(60)
0.05 4 1(3), 2(4), 3(9), 4(20) 1(2), 2(3), 3(8), 4(21)
0.01 5 1(2), 2(2), 3(2), 4(2),
5(5)
1(1), 2(1), 3(1), 4(1),
5(4)
0.005 3 1(2), 2(2), 3(5) 1(1), 2(1), 3(4)
0.001 1 1(2) 1(1)
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located in different gene networks in Figure 4, which
means that maybe we can merge these two gene net-
works together, (shown with red dash line in Figure 4),
and furthermore, can be consistent with existing biologi-
cal functions of these two genes to diabetes. Another
example, rs6912853 is interacted with rs2734990 under
a very significant P-value of 9.43 x 10
–5, but rs2734990
is located in intergenic area and do not have a record in
Gene Ontology until now, maybe we can make use of
rs6912853’s gene information, BTN3A1, to further ana-
lyze the inner functions of rs2734990 and extend GO
afterward.
In order to investigate the inner functions of the genes
involved in our gene network in an ontology level, we
performed the GO enrichment analysis by GOEAST
[40], which is a web-based software toolkit for fast iden-
tification of underlining biological relevance of high-
Table 3 Significance of selected SNP networks in different thresholds of T1D study.
PLINK thresholds NO. of networks Selected mean Random Significance value
mean variance
0.1 2 1(0.0985) 1(0.5648) 1(0.0991) 1.2672 × 10–6
2(0.0450) 2(0.5645) 2(0.1008) 1.2765 × 10–7
0.05 4 1(0.0298) 1(0.5805) 1(0.1018) 3.1578 × 10–8
2(0.0225) 2(0.5682) 2(0.0995) 2.0741 × 10–8
3(0.0306) 3(0.5638) 3(0.1005) 5.6191 × 10–8
4(0.0203) 4(0.5633) 4(0.1002) 2.9939 × 10–8
0.01 5 1(0.0054) 1(0.5862) 1(0.1003) 3.5062 × 10–9
2(0.0057) 2(0.5645) 2(0.0983) 6.5545 × 10–9
3(0.0012) 3(0.5622) 3(0.0971) 3.7898 × 10–9
4(0.0011) 4(0.5545) 4(0.1009) 2.0716 × 10–8
5(0.0015) 5(0.5528) 5(0.1004) 1.9979 × 10–8
0.005 3 1(0.0011) 1(0.5327) 1(0.1024) 1.0436 × 10–7
2(0.0012) 2(0.5300) 2(0.0998) 5.8348 × 10–8
3(0.0015) 3(0.5762) 3(0.1004) 5.1991 × 10–9
0.001 1 1(0.0001) 1(0.5578) 1(0.0950) 2.1721 × 10–9
Figure 2 SNP networks when PLINK threshold=0.1 of T1D study. SNP networks were constructed based on the P-value of PLINK epistasis
test using Cytoscape, all the pairwise SNP-SNP interactions that had a PLINK P-value smaller than 0.1 were involved in this SNP network. Each
node in the figure is labeled as its SNP ID and the edge between two SNPs indicates whether this pair of SNPs are interacted under a P <0 .1
significance level. This network includes 2 individual networks and 51 SNPs.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
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Page 7 of 17throughput experimental results. GOEAST discovers
statistically significantly enriched GO terms among the
given gene list based on their hypergeometric probabil-
ity. So the purpose of this analysis here is to find out
which GO terms can be strongly enriched or signifi-
cantly associated with our selected genes. We did a
Batch-Genes search using “Homo sapiens” background
for all the three GO categories: “molecular function”,
“biological process” and “cellular component”,a ss h o w n
in Figure 5, Figure 6 and Figure 7 respectively. In these
figures, boxes represent GO terms, labeled by its GOID,
term definition, P-value and detail information. Signifi-
cantly enriched GO terms are marked yellow. The
degree of color saturation of each node is positively cor-
related with the significance of enrichment of the corre-
sponding GO term. The detail information labeled in
the enriched GO nodes are organized as “q/m\t/k(p –
value)”,w h e r eq is the count of genes associated with
the listed GOID (directly or indirectly) in our dataset, m
is the count of genes associated with the listed GOID
(directly or indirectly) on the chosen platform, k is the
total number of genes in our dataset, t is the total
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
x
F
(
x
)
Empirical CDF
Figure 3 Cumulative distribution of 500 random SNP networks. Cumulative distribution of 500 random SNP networks. Each of these 500
random networks maintained the same size with our selected SNP network (49 SNPs). SNPs were selected randomly, calculated all pairwise SNP-
SNP interactions using PLINK, got the average P-value of all pairs. This cumulative distribution is a statistics of these 500 random networks with X
axis is the average P-value within this network and Y axis is the cumulative probability that within a particular X threshold.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
http://www.biomedcentral.com/1471-2105/12/S5/S4
Page 8 of 17number of genes on the chosen platform, p-value is of
the significance for the enrichment in the dataset of the
listed GOID under hypergeometric distribution. We also
extracted all the GO terms and the corresponding
involved genes with a significant P <0 .001, see Table 6.
We highlighted the GO termst h a tm a yb er e l a t e dt o
diabetes, which need to be further verified and investi-
gated by biologists.
Hirschsprung study
Data set and preprocessing
Hirschsprung (HSCR, MIM 142623), also known as agan-
glionic megacolon, is a congenital intestinal disease.
Patients suffer from different extent of aganglionosis due
to the absence of ganglion cells in the gastrointestinal
tract. Trisomy 21 (Down syndrome) is the most recurrent
structural variations found in HSCR, contributing to
2-10% of the cases.
Table 4 Detailed gene descriptions of SNPs selected in chromosome 6 of T1D study.
SNP ID Gene
Symbol
Gene
ID
Description
rs6940177 TRDN 10345 triadin
rs17209874 RUNX2 860 runt-related transcription factor 2
rs9479373 LOC646024 646024 locus-region
rs3778077 NUDT3 11165 nudix (nucleoside diphosphate linked moiety X)-type motif 3
rs16875181 GPR116 221395 G protein-coupled receptor 116
rs7754428 GMDS 2762 GDP-mannose 4,6-dehydratase
rs6902158 LRRC16 55604 leucine rich repeat containing 16
rs6912853 BTN3A1 11119 butyrophilin, subfamily 3, member A1
rs991974 LMBRD1 55788 chromosome 6 open reading frame 209
rs643394 LOC442256 442256 similar to PPP1R14B protein
rs9397339 PLEKHG1 57480 pleckstrin homology domain containing, family G (with RhoGef domain) member 1
rs319123 C6orf210 57107 chromosome 6 open reading frame 210
rs352095 FLJ34503 285759 hypothetical protein FLJ34503
rs1738262 DNAH8 1769 dynein, axonemal, heavy polypeptide 8
rs7760230 SNX9 51429 sorting nexin 9
rs10947885 LRFN2 57497 leucine rich repeat and fibronectin type III domain containing 2
rs1334689 EPB41L2 2037 erythrocyte membrane protein band 4.1-like 2
rs1406882 FYN 2534 FYN oncogene related to SRC, FGR, YES
rs1563666 LOC643281 643281 intron
rs9321142 LAMA2 3908 laminin, alpha 2 (merosin, congenital muscular dystrophy)
rs2073012 NOX3 50508 NADPH oxidase 3
rs11154452 LAMA2 3908 laminin, alpha 2 (merosin, congenital muscular dystrophy)
rs9394755 UNC5CL 222643 unc-5 homolog C (C. elegans)-like
rs9371491 MTHFD1L 25902 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like an enzyme involved in THF synthesis in
mitochondria
rs6918886 RPS6KA2 6196 ribosomal protein S6 kinase, 90kDa, polypeptide 2
Table 5 Gene networks formed for different threshold
values of T1D study.
GOSemSim
thresholds
Number of gene
pairs
Number of gene
networks
0.20 1 1
0.19 11 2
0.15-0.18 12 3
0.14 14 2
0.13 24 1
Figure 4 Gene network when GOSemSim threshold=0.15 of
T1D study. Gene network constructed using Cytoscape. In
chromosome 6 of T1D data, all SNPs selected belong to 24 unique
genes. All the pairwise similarity values of these 24 genes were
computed using GOSemSim and gene pairs that had a > 0.15
threshold were grouped together. Every node in the figure is
labeled as its gene symbol and the edge between two genes
indicates whether this pair of genes has a > 0.15 threshold or not.
This network includes 3 individual networks and totally 11 genes.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
http://www.biomedcentral.com/1471-2105/12/S5/S4
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Figure 5 GOEAST analysis in molecular function category of T1D study. The GOEAST graphical output of enriched GO terms in the
molecular function category for our selected gene network of T1D study. Boxes represent GO terms, labeled by its GO ID, term definition, and
detailed information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or indirectly) in
our dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total number of
genes in our dataset, t is the total number of genes on the chosen platform, p-value is of the significance for the enrichment in the dataset of
the listed GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation of each
node is positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the hierarchical
tree are shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows represent
connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent
relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
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Figure 6 GOEAST analysis in biological process category of T1D study. The GOEAST graphical output of enriched GO terms in the
biological process category for our selected gene network of T1D study. Boxes represent GO terms, labeled by its GO ID, term definition, and
detailed information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or indirectly) in
our dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total number of
genes in our dataset, t is the total number of genes on the chosen platform, p-value is of the significance for the enrichment in the dataset of
the listed GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation of each
node is positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the hierarchical
tree are shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows represent
connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent
relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
http://www.biomedcentral.com/1471-2105/12/S5/S4
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Figure 7 GOEAST analysis in cellular component category of T1D study. The GOEAST graphical output of enriched GO terms in the cellular
component category for our selected gene network of T1D study. Boxes represent GO terms, labeled by its GO ID, term definition, and detailed
information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or indirectly) in our
dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total number of genes in
our dataset, t is the total number of genes on the chosen platform, p-value is of the significance for the enrichment in the dataset of the listed
GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation of each node is
positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the hierarchical tree are
shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows represent
connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent
relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
Table 6 Gene Ontology terms significant associated with selected genes (P < 0.001) of T1D study.
GO Category GO ID GO Annotation Genes P-value
Molecular Function GO:0016175 superoxide-generating NADPH oxidase activity NOX3 0.000518
Molecular Function GO:0030507 spectrin binding EPB41L2 0.000518
Cellular Component GO:0005606 laminin-1 complex LAMA2 0.000518
Biological Process GO:0009629 response to gravity NOX3 0.000561
Biological Process GO:0009396 folic acid and derivative biosynthetic process MTHFD1L 0.000561
Cellular Component GO:0043256 laminin complex LAMA2 0.000561
Biological Process GO:0046653 tetrahydrofolate metabolic process MTHFD1L 0.000641
Cellular Component GO:0008091 spectrin EPB41L2 0.000641
Cellular Component GO:0043020 NADPH oxidase complex NOX3 0.000758
Molecular Function GO:0050664 oxidoreductase activity, acting on NADH or NADPH, with oxygen as acceptor NOX3 0.000880
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
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Page 11 of 17This data set consists of 330 controls and 121 cases of
Chinese ethnicity. In this analysis, we excluded the cen-
tromeric and telomeric regions using 500kb threshold
because these regions tend to have bias in CNV calling.
We transformed the probe intensities into LRR values
from this SNP data set (n=3369) using PennCNV with
the same parameter setting and procedure as mentioned
above.
Classification results
After a 10-fold cross validation, 406 samples were
selected as the training set and the remaining 45 sam-
ples were used as the testing set. Figure 8 illustrated the
relationship of Δ and accuracy for our method. Our
method achieved the optimal accuracy of 84.44%, when
the threshold of Δ was set either between 0.2 – 0.4o r
0.6 – 3.1. We showed all the 6 SNPs selected when Δ is
0 1 2 3 4 5 6 7 8 9 10
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Figure 8 Relationship between Delta and accuracy in chromosome 21 of Hirschsprung study. Illustration of the accuracy obtained in
chromosome 21 of Hirschsprung data set when change Δ value from 0 to 10. For chromosome 21, in each trial, all the 451 samples of both
control and case were randomly divided into 10 equal partitions. For each of the 10 partition groups, we selected one of them as testing set
and the remaining nine of them were considered as training sets. 10 trials were considered and the results were collected based on this 10-fold
cross validation procedure. This figure was drawn based on one of these ten trails when the highest accuracy (accuracy refers to the percentage
of correctly classified samples over all test samples) was obtained. X axis refers to Δ value, it increases from 0 to 10. Y axis refers to the accuracy
obtained in chromosome 21 when using our method, it fluctuates when different Δ values are applied and the highest accuracy is obtained
when Δ is equal to 3.1.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
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Page 12 of 17equal to 3.1 in Table 7, it includes the average and var-
iance of LRR values in each SNP position within case
and control group respectively.
As there are only 6 SNPs selected, the number is too
small to construct any networks. So for this dataset, we
did not do any analysis in SNP level.
Gene network construction and analysis
All the 6 SNPs selected by our method belong to 3
unique genes. The detailed gene information can be
seen in Table 8. We calculated all the pairwise gene
similarity values with the same parameter settings of
previous data set. If define a threshold of 0.01, all these
3 genes can be linked together, see Figure 9. After a sur-
vey in the literature about the known findings of these 3
genes, we found some interesting phenomena. For gene
DSCAM, which is a previously implicated gene for the
involvement of developing hirschsprung disease [41,42],
and for gene TMPRSS15, whose mutations can cause
enterokinase deficiency, a malabsorption disorder char-
acterized by diarrhea and failure to thrive, both of these
two genes have a biological record that directly to
hirschsprung disease, and both of them can be selected
as relevant features using our method, furthermore, can
be grouped together in our gene network, which can
strongly prove the efficiency of our model.
F o rt h eg e n en e t w o r ks h o w ni nF i g u r e9 ,t h es a m e
procedure of enrichment analysis using GOEAST was
done, see Figures 10, 11, 12. Table 9 shows a detailed
description of GO terms with a significant P <0 .0001,
which can provide an inner functions of our selected
genes.
Conclusions
In this paper, we use the method of nearest shrunken
centroid for gene expression data, and apply it to tackle
copy number variation data determined from genome-
wide SNP arrays. The method can be implemented on a
personal computer very efficiently. The relevant SNPs
are selected for disease data. Experimental results are
reported to show the effectiveness of our method. In
particular, we find some SNPs that contain in some
genes which are relevant to a particular disease. Based
on the SNP and gene networks, we can find out some
unknown relationships between their corresponding
genes, which can be considered as an extension of exist-
ing GO knowledge. The existing Gene Ontology enrich-
ment analysis tool also suggests that our selected genes
are associated to some molecular function and biological
process. In the future, we will study the following pro-
blems. Detailed biological analysis of CNVs determined
from other genome-wide SNP data sets will be studied.
Statistical and association study of selected SNPs can be
carried out.
Table 7 Distribution of LRR values for selected SNPs of
Hirschsprung study.
SNP ID dik
’
Control Case
mean variance mean variance
rs11701130 1.0256 -0.1325 0.1130 0.1821 0.0686
rs2837770 0.4607 -0.1387 0.1014 0.1208 0.0578
rs2824050 0.3089 -0.0559 0.0331 0.1185 0.0214
rs928862 0.2301 -0.0934 0.0632 0.1193 0.0339
rs2824724 0.2177 -0.1012 0.1169 0.1439 0.0626
rs845930 0.1205 -0.1543 0.2580 0.1668 0.1373
Table 8 Detailed descriptions of SNPs selected in
chromosome 21 of Hirschsprung study.
SNP ID Gene
Symbol
Gene
ID
Description
rs11701130 intergenic
rs2837770 DSCAM 1826 Down syndrome cell adhesion
molecule
rs2824050 intergenic
rs928862 intergenic
rs2824724 TMPRSS15 5651 Mutations in this gene cause
enterokinase deficiency, a
malabsorption disorder characterized
by diarrhea and failure to thrive
rs845930 TIAM1 7074 T-cell lymphoma invasion and
metastasis 1
Figure 9 Gene network when GOSemSim threshold=0.01 of
Hirschsprung study. Gene network constructed using Cytoscape.
In chromosome 21 of Hirschsprung data, all SNPs selected belong
to 3 unique genes. All the pairwise similarity values of these 3
genes were computed using GOSemSim and gene pairs that had a
>0 .01 threshold were grouped together. Every node in the figure is
labeled as its gene symbol and the edge between two genes
indicates whether this pair of genes has a > 0.01 threshold or not.
This network includes 1 individual network and 3 unique genes.
Liu et al. BMC Bioinformatics 2011, 12(Suppl 5):S4
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Figure 11 GOEAST analysis in biological process category of Hirschsprung study. The GOEAST graphical output of enriched GO terms in
the biological process category for our selected gene network of Hirschsprung study. Boxes represent GO terms, labeled by its GO ID, term
definition, and detailed information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or
indirectly) in our dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total
number of genes in our dataset, t is the total number of genes on the chosen platform, p-value is of the significance for the enrichment in the
dataset of the listed GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation of
each node is positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the hierarchical
tree are shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows represent
connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent
relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
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Figure 10 GOEAST analysis in molecular function category of Hirschsprung study. The GOEAST graphical output of enriched GO terms in
the molecular function category for our selected gene network of Hirschsprung study. Boxes represent GO terms, labeled by its GO ID, term
definition, and detailed information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or
indirectly) in our dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total
number of genes in our dataset, t is the total number of genes on the chosen platform, p–value is of the significance for the enrichment in the
dataset of the listed GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation of
each node is positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the hierarchical
tree are shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows represent
connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent
relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
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Figure 12 GOEAST analysis in cellular component category of Hirschsprung study. The GOEAST graphical output of enriched GO terms in
the cellular component category for our selected gene network of Hirschsprung study. Boxes represent GO terms, labeled by its GO ID, term
definition, and detailed information, organized as “q/m|t/k(p – value)”, where q is the count of genes associated with the listed GOID (directly or
indirectly) in our dataset, m is the count of genes associated with the listed GOID (directly or indirectly) on the chosen platform, k is the total
number of genes in our dataset, t is the total number of genes on the chosen platform, p-value is of the significance for the enrichment in the
dataset of the listed GOID under hypergeometric distribution. Significantly enriched GO terms are marked yellow. The degree of color saturation
of each node is positively correlated with the enrichment significance of the corresponding GO term. Nonsignificant GO terms within the
hierarchical tree are shown as white boxes. Branches of the GO hierarchical tree without significantly enriched GO terms are not shown. Arrows
represent connections between different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows
represent relationships between enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO
terms.
Table 9 Gene Ontology terms significant associated with selected genes (P < 0.0001) of Hirschsprung study.
GO Category GO ID GO Annotation Genes P-value
Biological Process GO:0050772 positive regulation of axonogenesis DSCAM, TIAM1 0.000000736
Biological Process GO:0031346 positive regulation of cell projection organization DSCAM, TIAM1 0.000005400
Biological Process GO:0048013 ephrin receptor signaling pathway TIAM1 0.000024800
Biological Process GO:0031344 regulation of cell projection organization DSCAM, TIAM1 0.000030600
Biological Process GO:0009886 post-embryonic morphogenesis DSCAM 0.000038400
Biological Process GO:0048841 regulation of axon extension involved in axon guidance DSCAM 0.000045900
Molecular Function GO:0046875 ephrin receptor binding TIAM1 0.000053600
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